Clinical experience of conversion from cyclosporine to tacrolimus prolonged-release in stabilized kidney transplant patients

Clinical experience of conversion from cyclosporine to tacrolimus prolonged-release in stabilized kidney transplant patients

Background and Aims: The CONCERTO study results showing the beneficial effects of conversion from cyclosporine to tacrolimus prolonged-release (tacrolimus PR) in stabilised patients after kidney transplantation, were first published in 2011. This communication describes our first experience of conve...

Full description

Bibliographic Details
Main Authors:	Karel Krejci, Josef Zadrazil, Eva Lackova, Zuzana Zilinska, Robert Roland, Ivana Dedinska
Format:	Article
Language:	English
Published:	Palacký University Olomouc, Faculty of Medicine and Dentistry 2016-09-01
Series:	Biomedical Papers
Subjects:	tacrolimus prolonged-release cyclosporine immunosuppressive conversion kidney transplantation
Online Access:	https://biomed.papers.upol.cz/artkey/bio-201603-0011_Clinical_experience_of_conversion_from_cyclosporine_to_tacrolimus_prolonged-release_in_stabilized_kidney_transp.php

Similar Items

Sirolimus and tacrolimus rather than cyclosporine A cause bone loss in healthy adult male rats
by: Mercedes Rubert, et al.
Published: (2015-06-01)

Ciclosporina A e tacrolimus: uma revisão Cyclosporine A and tacrolimus: a review
by: Solange Cristina Garcia, et al.
Published: (2004-12-01)

Analyses of AUC<sub>(0–12)</sub> and C<sub>0</sub> Compliances within Therapeutic Ranges in Kidney Recipients Receiving Cyclosporine or Tacrolimus
by: Aurelija Radzevičienė, et al.
Published: (2020-12-01)

Comparison of Semen Analysis Parametes Changes after Priscription of Two Immunosuppresive Drugs, Tacrolimus and Cyclosporine in Men Undergoing Renal Transplantation
by: Ali Ramouz, et al.
Published: (2017-02-01)

Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
by: O. N. Rzhevskaya, et al.
Published: (2018-08-01)

Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)

Clinical laboratory aspects of one-component immunosuppression during liver transplantation
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)

Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus
by: Ana Elena Rodríguez-Rodríguez, et al.
Published: (2015-05-01)

Real-World Administration of Once-Daily MeltDose<sup>®</sup> Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation
by: Katharina Willuweit, et al.
Published: (2021-12-01)

Systemic tacrolimus in the treatment of recalcitrant mucosal lichen planus
by: Edward Chen, BA, et al.
Published: (2017-05-01)

Effective Tacrolimus Treatment for Patients with Non-Severe Aplastic Anemia That is Refractory/Intolerant to Cyclosporine A: A Retrospective Study
by: Du Y, et al.
Published: (2020-12-01)

Efficacy and safety of cyclosporine versus tacrolimus in steroid and cyclophosphamide resistant nephrotic syndrome: A prospective study
by: N Prasad, et al.
Published: (2018-01-01)

Comparative Evaluation of Tacrolimus and Cyclosporine in Patients with Steroid-resistant Nephrotic Syndrome: A Systematic Review and Meta-analysis
by: Yalda Ravanshad, et al.
Published: (2019-09-01)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
by: Majda Sahman, et al.
Published: (2021-03-01)

Influence of different formulations of tacrolimus on dosage regimen and drug exposure within the first year after kidney transplantation
by: Stefanović Nikola Z., et al.
Published: (2019-01-01)

Effect of <i>CYP3A5</i> on the Once-Daily Tacrolimus Conversion in Stable Liver Transplant Patients
by: Jong Man Kim, et al.
Published: (2020-09-01)

Tacrolimus for the Treatment of Ulcerative Colitis
by: Katsuyoshi Matsuoka, et al.
Published: (2015-07-01)

Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach
by: Daniele Giovanni Ghiglioni, et al.
Published: (2020-04-01)

Periodontal Microbiological Status Influences the Occurrence of Cyclosporine-A and Tacrolimus-Induced Gingival Overgrowth
by: Biagio Rapone, et al.
Published: (2019-08-01)

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
by: Arnaud Del Bello, et al.
Published: (2021-10-01)

Comparison of patient and graft survival in tacrolimus versus cyclosporine-based immunosuppressive regimes in renal transplant recipients – Single-center experience from South India
by: Kiran Chandra Patro, et al.
Published: (2018-01-01)

Transplant Recipients Using Tacrolimus Had Higher Utilization of Healthcare Services Than Those Receiving Cyclosporine in Taiwan
by: Yi-Chang Lin, et al.
Published: (2019-09-01)

The effects of immunosuppressive agents on inflammatory response in septic rats
by: Filiz Ali, et al.
Published: (2010-12-01)

The parameters of Cyclosporine A induced inhibition of a T cell dependent antibody response
by: Schilke, Angela J.
Published: (2011)

Cyclosporine A and Tacrolimus Induce Functional Impairment and Inflammatory Reactions in Endothelial Progenitor Cells
by: Nadia Meyer, et al.
Published: (2021-09-01)

Pharmacokinetic and biopharmaceutical studies of cyclosporine in the dog and of salicylate in humans.
by: Abdallah, Hisham Youssef.
Published: (1989)

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
by: Gerold Thölking, et al.
Published: (2020-01-01)

Function of external respiration in patients after kidney transplantation under conditions of immunosuppressive therapy.
by: O. V. Kuryata, et al.
Published: (2018-04-01)

Tacrolimus-induced Ascites after Liver Transplant
by: M Hosseini, et al.
Published: (2018-04-01)

Low-dose cyclosporine treatment for sight-threatening uveitis: Efficacy, toxicity, and tolerance
by: Mathews D, et al.
Published: (2010-01-01)

Tacrolimus-induced pure red cell aplasia in a postrenal transplant patient
by: Prakash Khetan, et al.
Published: (2019-01-01)

Protective effect of resveratrol on the kidney in rats under immunosuppression with tacrolimus
by: Asuman Kilitci, et al.
Published: (2021-02-01)

Improving Production of Tacrolimus In Streptomyces Tacrolimicus (ATCC 55098) Through Development of Novel Mutant by Dual Mutagenesis
by: Bhanu P Singh, et al.
Published: (2017-08-01)

FIRST EXPERIENCE IN SYSTEMIC ADMINISTRATION OF EVEROLIMUS IN RENAL TRANSPLANTATION FROM EXPANDED CRITERIA DONORS IN RUSSIAN FEDERATION
by: I. V. Uliyankina, et al.
Published: (2017-01-01)

Efek samping pada rongga mulut akibat terapi siklosporin Side effect in oral cavity due to cyclosporine therapy
by: Rifi Aranti, et al.
Published: (2013-02-01)

Is Cyclosporine Ototoxic?
by: Sofia Waissbluth
Published: (2020-10-01)

The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections
by: Paulina Glowacka, et al.
Published: (2020-07-01)

Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?
by: Paolo Carta, et al.
Published: (2020-05-01)

CORNEAL GRAFT REJECTION AFTER KERATOPLASTY
by: S. V. Trufanov, et al.
Published: (2017-10-01)

Foremost Concepts in Mechanisms of De Novo Post-Liver Transplantation Malignancy
by: Milena Peruhova, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_2ji6lohobp7mt06dshr9mfi9b0